Company Filing History:
Years Active: 2022-2025
Title: The Innovative Contributions of Peter Steidle
Introduction
Peter Steidle is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that target cancer treatment. With a total of 3 patents to his name, Steidle's work has the potential to impact the medical community profoundly.
Latest Patents
Among his latest patents, Steidle has developed pharmaceutical compositions comprising AKT protein kinase inhibitors. These inventions focus on therapeutic activities against diseases such as cancer. The processes for their preparation and their use as medicaments highlight the innovative nature of his work in the pharmaceutical industry.
Career Highlights
Throughout his career, Peter Steidle has worked with prominent companies in the pharmaceutical sector, including Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development.
Collaborations
Steidle has collaborated with several professionals in his field, including Reinhard Reents and Pirmin Hidber. These partnerships have likely enhanced the quality and scope of his inventions, fostering a collaborative environment for innovation.
Conclusion
Peter Steidle's contributions to pharmaceutical innovations, particularly in cancer treatment, demonstrate his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving therapeutic options for patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.